| Literature DB >> 28629174 |
Mengqi Huo1, Zhixin Wang2, Dongxue Wu3, Yanling Zhang4, Yanjiang Qiao5.
Abstract
Salvia miltiorrhiza, known as Danshen, has attracted worldwide interest for its substantial effects on coronary heart disease (CHD). Danshensu (DSS) is one of the main active ingredients of Danshen on CHD. Although it has been proven to have a good clinical effect on CHD, the action mechanisms remain elusive. In the current study, a coexpression network-based approach was used to illustrate the beneficial properties of DSS in the context of CHD. By integrating the gene expression profile data and protein-protein interactions (PPIs) data, two coexpression protein interaction networks (CePIN) in a CHD state (CHD CePIN) and a non-CHD state (non-CHD CePIN) were generated. Then, shared nodes and unique nodes in CHD CePIN were attained by conducting a comparison between CHD CePIN and non-CHD CePIN. By calculating the topological parameters of each shared node and unique node in the networks, and comparing the differentially expressed genes, target proteins involved in disease regulation were attained. Then, Gene Ontology (GO) enrichment was utilized to identify biological processes associated to target proteins. Consequently, it turned out that the treatment of CHD with DSS may be partly attributed to the regulation of immunization and blood circulation. Also, it indicated that sodium/hydrogen exchanger 3 (SLC9A3), Prostaglandin G/H synthase 2 (PTGS2), Oxidized low-density lipoprotein receptor 1 (OLR1), and fibrinogen gamma chain (FGG) may be potential therapeutic targets for CHD. In summary, this study provided a novel coexpression protein interaction network approach to provide an explanation of the mechanisms of DSS on CHD and identify key proteins which maybe the potential therapeutic targets for CHD.Entities:
Keywords: Danshensu (DSS); coexpression protein interaction network (CePIN); coronary heart disease (CHD); targets
Mesh:
Substances:
Year: 2017 PMID: 28629174 PMCID: PMC5486119 DOI: 10.3390/ijms18061298
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The whole framework of this study is based on a coexpression protein interaction network (CePIN) for the identification of mechanisms for the treatment of coronary heart disease (CHD) with Danshensu (DSS).
Proteins information of Danshensu (DSS).
| Uniprot ID | Proteins | Source | Uniprot ID | Proteins | Source |
|---|---|---|---|---|---|
| P09601 | HMOX1 | STITCH | P12821 | ACE | Pharmacophore |
| P30556 | AGTR1 | Pharmacophore | P09917 | ALOX5 | Pharmacophore |
| P25101 | EDNRA | Pharmacophore | P29466 | CASP1 | Pharmacophore |
| P24530 | EDNRB | Pharmacophore | P00742 | F10 | Pharmacophore |
| P24941 | CDK2 | Pharmacophore | - | - | - |
Heme oxygenase 1 (HMOX1); type-1 angiotensin II receptor (AGTR1); endothelin-1 receptor (EDNRA); endothelin B receptor (EDNRB); cyclin-dependent kinase 2 (CDK2); angiotensin-converting enzyme (ACE); arachidonate 5-lipoxygenase (ALOX5); caspase-1 (CASP1); coagulation factor X (F10).
Figure 2(A) Coexpression protein interaction networks (CePIN) in a non-CHD state (non-CHD CePIN) and (B) coexpression protein interaction networks (CePIN) in a CHD state (CHD CePIN). Nodes in green color are unique nodes in non-CHD CePIN; those in yellow color are shared nodes both in non-CHD CePIN and CHD CePIN; those in pink color are unique nodes in CHD CePIN; and the blacklines are interactions between nodes.
Structural analysis of coexpression protein interaction networks (CePIN).
| Items | Proteins | CePPIs |
|---|---|---|
| CHD CePIN | 91 | 98 |
| Non-CHD CePIN | 99 | 110 |
| Overlap amount | 66 | 33 |
| Overlap ratio | 69% | 32% |
Nodes with the highest degree and betweenness values in CHD CePIN.
| Name | Category | Hub/Bottleneck | Betweenness | Degree |
|---|---|---|---|---|
| EDN1 | shared | hub-bottleneck | 0.63673203 a | 7 b |
| FGG | unique | bottleneck | 0.51450980 a | 4 |
| SLC9A3 | unique | bottleneck | 0.49411765 a | 2 |
| STAT3 | shared | bottleneck | 0.48627451 a | 2 |
| F10 | shared | - | 0.41058824 | 5 |
| JUN | shared | hub | 0.37490196 | 7 b |
| F8 | shared | - | 0.32156863 | 4 |
| KNG1 | shared | hub | 0.28313725 | 7 b |
| CCND1 | unique | - | 0.21803922 | 3 |
| TBXA2R | shared | - | 0.15137255 | 5 |
| Average | - | - | 0.091432882 | 2.7307692 |
| +1 SD | - | - | 0.254025973 | 4.4810116 |
| +2 SD | - | - | 0.416619064 | 6.2312540 |
a,b Refers to nodes with values of betweenness and degree above two standard deviations (+2 SD) compared with thresholds, resp. hub-bottleneck refers to a node both hub and bottleneck. Endothelin-1 (EDN1); fibrinogen gamma chain (FGG); sodium/hydrogen exchanger 3 (SLC9A3); signal transducer and activator of transcription 3 (STAT3); coagulation factor X (F10); transcription factor AP-1 (JUN); coagulation factor VIII (F8); kininogen-1 (KNG1); G1/S-specific cyclin-D1 (CCND1); thromboxane A2 receptor (TBXA2R); Average refers to average of betweenness and degree of all nodes, +1 SD refers to values of betweenness and degree above one standard deviations (+1 SD), +2 SD refers to values of betweenness and degree above two standard deviations (+2 SD).
Figure 3CHD CePIN colored based on the betweenness of each node. Red (least) → light red → yellow → light blue → blue (greatest). Shared nodes are on the left, and unique nodes are on the right.
Topological parameters of CHD CePIN after candidate targets removal.
| Removed Node | Category | Hub/Bottleneck | Shortest Paths | Characteristic Path Length | Network Diameter |
|---|---|---|---|---|---|
| EDN1 | shared | hub-bottleneck | 988 (38%) | 3.332 | 7 |
| FGG | unique | bottleneck | 1238 (48%) | 3.313 | 7 |
| SLC9A3 | unique | bottleneck | 1232 (50%) | 3.344 | 7 |
| STAT3 | shared | bottleneck | 1310 (51%) | 3.382 | 7 |
| KNG1 | shared | hub | 1828 (71%) | 4.658 | 11 |
| JUN | shared | hub | 1934 (75%) | 5.411 | 12 |
| without removing | - | - | 2652 (100%) | 5.572 | 13 |
Figure 4Modules in CHD CePIN. With the fast agglomerate algorithm based on the edge clustering coefficients (FAG-EC) algorithm, nine modules were extracted from the network.
Gene Ontology (GO) biological process terms of the CHD CePIN modules.
| Module | Description | |
|---|---|---|
| 1 | 7.76 × 10−9 | inflammatory response |
| 2 | 4.89 × 10−7 | G-protein-coupled receptor signaling pathway |
| 3 | 4.91 × 10−11 | regulation of cell cycle |
| 4 | 5.23 × 10−11 | heme catabolic process |
| 5 | 6.08 × 10−8 | regulation of I-κB kinase/NF-κB signaling |
| 6 | 4.89 × 10−9 | blood coagulation |
| 7 | 2.12 × 10−10 | arachidonic acid metabolic process |
| 8 | 1.42 × 10−6 | regulation of blood volume by renin-angiotensin |
| 9 | 1.51 × 10−7 | G-protein-coupled receptor signaling pathway |
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB); Inhibitor of nuclear factor kappa-B kinase (I-κB).